Netflix (NFLX) Offering Possible 53.85% Return Over the Next 13 Calendar Days

Netflix's most recent trend suggests a bullish bias. One trading opportunity on Netflix is a Bull Put Spread using a strike $495.00 short put and a strike $490.00 long put offers a potential 53.85% return on risk over the next 13 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $495.00 by expiration. The full premium credit of $1.75 would be kept by the premium seller. The risk of $3.25 would be incurred if the stock dropped below the $490.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Netflix is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Netflix is bullish.

The RSI indicator is at 58.3 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Netflix

AT&T's HBO Max Strategy Change Doesn't Go Far Enough — Not Yet, Anyway
Fri, 04 Dec 2020 01:59:00 +0000
If AT&T; is serious about making HBO Max a top-tier streaming player, it needs to provide first-day access to Warner Bros. films permanently, rather than until the end of 2021.

‘Dune' at Home Turns Theaters Into Wasteland
Thu, 03 Dec 2020 21:47:37 +0000
(Bloomberg Opinion) — Warner Bros. and HBO Max, two units of AT&T Inc., just delivered a crushing blow to movie theaters. All of the studio’s films set for release next year — including “The Suicide Squad,” “Dune” and “The Matrix 4” — will go straight to the HBO Max streaming service at the same time that they play in cinemas. While Warner executive Ann Sarnoff sees it as a “unique one-year plan,” let’s be honest, it’s not. Even as Covid-19 vaccines near approval, it could be a while before consumers feel safe returning to the close confines of a shut-in movie theater. In the latest Morning Consult poll of 2,200 U.S. adults conducted in the final days of November, 51% said it would be four to six months or even longer before they’d feel comfortable resuming trips to the movies; another 26% said they didn’t know or didn’t have an opinion on it. By the time most people do feel safe going, many still may not want to. What I wrote in October — as exhibitor AMC Entertainment Inc. warned of possible bankruptcy — bears repeating:We have learned to live without movie theaters. Even the ones that make it through the crisis may find that online-streaming apps have stolen away audiences for good.Unlike amusement-park rides and cruises, which have been equally paralyzed by the pandemic, the movie experience can be replicated at home — and sometimes more cheaply and conveniently. It will be that much harder for theater chains to bounce back. The place cinemas have in our culture and history, and the thousands of jobs they provide, makes it all the more tragic. But consumers keep signaling that going to the movies is more of an occasional treat when there’s a must-see blockbuster film than a regular habit. That’s not enough to support 40,449 movie screens in the U.S., the latest total published by the National Association of Theater Owners. As I noted in October, higher ticket prices have helped give the false sense that box-office sales are climbing, when in fact adjusting for inflation shows that they’ve gradually fallen over the last 20 years:Companies such as AT&T and Walt Disney Co. are responding as they must by going where audiences are. And that’s at home. The box office is a crucial source of profit for the Hollywood giants, but prioritizing that over streaming will only hurt them in the long run as Netflix Inc. rounds the corner on 200 million subscribers. The first domino fell in July, when Comcast Corp.’s Universal Studios struck an agreement with AMC to cut short the time its films play exclusively at theaters. Then Disney, the single most important company to movie-theater businesses, bypassed them and put “Mulan” directly on Disney+ in September for a viewing fee of $30. Last week, I wrote that Disney+ would be smart to offer a “box-office pass” subscription tier for movie fans willing to pay up for continuing virtual access to new theatrical releases. HBO Max, which costs $15 a month, won't charge anything extra for its films, for now at least.Shares of AT&T popped slightly on its announcement Thursday, while AMC and Cinemark Holdings Inc. plunged 16% and 22%, respectively. Just beforehand, as my colleague Brian Chappatta noted, AMC’s most-traded bonds had rallied to 35 cents, up from only 5 cents in early November. As for Disney and its peers, streaming has been a money-losing venture so far. But the fastest way to start turning a profit is to sign up lots of people. And Netflix has shown that the way to do that is to flood them with content — all the better if it’s movie-theater-quality films. Now that Warner Bros. is planning to do just that in 2021, it’s hard to imagine them turning back. This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tara Lachapelle is a Bloomberg Opinion columnist covering the business of entertainment and telecommunications, as well as broader deals. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

Warner Bros. says it will release 17 films to HBO Max streaming service as they hit theaters
Thu, 03 Dec 2020 19:20:00 +0000
Shattering movie-release norms, AT&T Inc.'s Warner Bros. on Thursday said it will release 17 films — including “Dune,” “The Matrix 4” and “The Suicide Squad” — to its HBO Max streaming service for 31 days the same day they debut on the silver screen. The unprecedented strategy comes amid the worst stretch of the COVID-19 pandemic, which has forced the closure of movie theaters nationwide. Warner previously said “Wonder Woman 1984” will be available on HBO Max as well as theaters on Dec. 25. The studio's slate of 2021 releases include the aforementioned three movies plus “Godzilla vs. Kong” and “Space Jam: A New Legacy.” The bold moves come as Warner Bros. competes with streaming services from Apple Inc. , Walt Disney Co. , Netflix Inc. , Amazon.com Inc. and others as more Americans view their entertainment from digital devices.

The Zacks Analyst Blog Highlights: Facebook, Netflix, AbbVie, American Airlines and Micron Technology
Thu, 03 Dec 2020 16:38:04 +0000
The Zacks Analyst Blog Highlights: Facebook, Netflix, AbbVie, American Airlines and Micron Technology

Discovery (DISCA) Enters Crowded Streaming Market
Thu, 03 Dec 2020 14:19:37 +0000
Discovery's (DISCA) new subscription video-on-demand service will have to compete for limited subscriber funds.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.